How many months can I usually take entrectinib?

EntrectinibIt is used to treat adults with non-small cell lung cancer that has spread to other parts of the body. Entrectinib is also used to treat certain types of solid tumors in adults and children 12 years and older that cannot be treated with surgery or have spread to other parts of the body and get worse after treatment with other chemotherapy drugs.

According to clinical data, patients need to take the drug for about 6 months to see good effects, and the specific time varies depending on the patient's condition. A total of 161 patients with follow-up time ≥ 6 months were evaluable, with a median treatment duration of 10.7 months. ORR is 67.1%, and the response is durable (12 months DoRThe rate was 63%, and the median DoR was 15.7 months). Entrectinib is administered orally and has a plasma half-life of 20 to 22 hours, allowing continuous once-daily dosing.

Entrectinib is a tyrosine kinase inhibitor that acts on several receptors. Inhibits tropomyosin receptor tyrosine kinase (TRK) asATPcompetitorTRKA, TRKB , TRKC, and the proto-oncogenes tyrosine-protein kinase ROS1 and anaplastic lymphoma kinase (ALK). TRKReceptors produce cell proliferation through downstream signaling of mitogen-activated protein kinase, phosphoinositide 3-kinase, and phospholipase C-γ. ALKBy adding downstream JAK/STATActivation produces a similar signal. Inhibition of these pathways inhibits cancer cell proliferation and shifts the balance in favor of apoptosis, resulting in tumor size reduction. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0

xa0